Summary

The global Plastic Biliary Stent market is projected to grow from US$ 54.58 million in 2025 to US$ 85.43 million by 2032, at a CAGR of 6.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Plastic Biliary Stent is the established market term for a sterile, single-use, radiopaque and non-self-expanding polymeric implant used to maintain biliary patency and provide temporary internal drainage. Also described as a plastic bile duct stent, biliary plastic stent or polymeric biliary stent, the product is placed mainly through endoscopic retrograde cholangiopancreatography, with selected systems supporting percutaneous-to-internal conversion. It is manufactured from polyethylene, polytetrafluoroethylene, polyurethane, ethylene-vinyl acetate or related medical-grade polymers and incorporates drainage side holes, radiopaque components and migration-control features such as flaps, bends or pigtail loops. The market covers stand-alone stents, stent-and-pusher sets, introducer systems and preloaded short-wire or long-wire delivery systems. Key specifications include French diameter, working length, geometry, polymer composition, guidewire compatibility and delivery configuration. Mainstream products concentrate at 7, 8.5 and 10 Fr, with common working lengths of 5–15 cm, while broader portfolios extend to approximately 11.5 Fr and 18 cm. The study focuses on straight-profile, pigtail and other specialty plastic biliary stents used for benign biliary strictures, temporary management of malignant obstruction, incomplete bile duct stone clearance, bile leakage, biliary fistula and related short- to medium-term drainage requirements.
Key Findings
In 2025, global Plastic Biliary Stent production reached approximately 483 K Units, with an average global market price of around US$ 113 per unit.
Mainstream plastic biliary stents cluster at 7, 8.5 and 10 Fr, with common working lengths of 5–15 cm
Straight-profile stents form the broadest unit segment, while pigtail and specialty designs address migration-sensitive anatomy
North America leads high-value demand, while Asia-Pacific contributes the strongest incremental unit growth
Market Trends
The product category is moving from basic polymer tubes toward procedure-optimized drainage systems. Development priorities include larger effective inner lumens, smoother internal surfaces, reduced sludge adhesion, stronger radiopacity, atraumatic tips and better control of migration without compromising removability. Boston Scientific’s Advanix platform emphasizes flow, pushability, repositionability and preloaded delivery, while Olympus uses a double-layer structure with a smoother inner surface to address patency and clogging concerns. These approaches illustrate competition shifting from polymer price toward total procedural efficiency and reliable short-term drainage. Short-wire compatibility, preloaded configurations and color-coded sizing reduce exchange steps and support standardized ERCP workflows. Demand is also becoming more application-specific: multi-stent protocols remain important for benign and post-transplant anastomotic strictures, pigtail designs are preferred where retention is critical, and readily removable plastic stents remain useful when diagnosis or treatment duration is uncertain. Plastic products will coexist with self-expanding metal stents rather than being fully replaced because they retain advantages in unit cost, removability, repeat placement and multi-duct drainage. Boston Scientific product portfolio Olympus double-layer stent
Market Dynamics
Drivers
Demand is supported by the continuing clinical burden of choledocholithiasis, benign postoperative and inflammatory strictures, pancreaticobiliary malignancies and complications following hepatobiliary surgery or liver transplantation. Expansion of therapeutic ERCP capacity increases the number of hospitals capable of placing and exchanging stents, while aging populations enlarge the patient pool requiring biliary decompression. Plastic stents generate recurring consumable demand because benign-stricture therapy may involve sequential dilation, multiple parallel stents and scheduled exchange. They are also required when complete stone extraction cannot be achieved during the initial ERCP, allowing temporary drainage before definitive treatment. Compared with permanent or longer-duration solutions, their removability supports staged treatment, uncertain pathology and bridge-to-surgery scenarios. Growth is additionally reinforced by broader availability of preloaded systems, compatible guidewires and standardized accessories, which improves procedural consistency and enables suppliers with integrated ERCP portfolios to bundle products, training and hospital support.
Restraints
Limited patency remains the main structural restraint. Bacterial biofilm, biliary sludge and side-hole blockage can lead to recurrent obstruction, cholangitis and unplanned replacement, while migration or difficult retrieval may create additional procedures. For longer-duration palliation of malignant obstruction, self-expanding metal stents can provide a larger lumen and longer patency, narrowing the role of conventional plastic products. Repeated ERCP also increases total treatment cost despite the lower unit price of the stent itself. Pricing pressure is pronounced in centralized procurement and hospital tenders: a 2025 Chinese hospital procurement notice budgeted an 8.5–10 Fr plastic biliary stent-and-guide system at RMB 892.04 per unit, illustrating the limited pricing headroom for standard configurations; the figure is a configuration-specific tender reference rather than a global average selling price. Reimbursement limitations, dependence on fluoroscopy and skilled endoscopists, and constrained ERCP access in lower-resource markets further restrict adoption. 2025 procurement notice.
Opportunities
The strongest opportunities lie in products that extend patency while preserving the cost and removability advantages of plastic. Low-friction inner layers, improved polymer formulations, anti-biofilm surfaces, optimized side-hole geometry and thin-wall construction could increase drainage performance without moving into metal-stent pricing. Preloaded and repositionable systems offer additional value by shortening procedure time and reducing accessory exchanges. Emerging Asian, Latin American and selected Middle Eastern markets provide incremental volume opportunities as ERCP training and tertiary-hospital infrastructure expand. Application-led growth can also arise from standardized multiple-plastic-stent protocols for benign strictures, transplant-related anastomotic disease, temporary drainage after difficult stone treatment and management of postoperative bile leaks. Specialized percutaneous-to-internal systems create a separate opportunity for interventional radiology departments and patients who cannot undergo conventional endoscopic placement. Manufacturers capable of pairing broad size matrices with local registration, physician education, reliable inventory and competitively priced delivery kits are best positioned to convert these opportunities into repeat sales.
Challenges
Manufacturers must balance lumen size, flexibility, pushability, kink resistance, radiopacity, migration control and atraumatic removal within a narrow polymer profile. Small variations in extrusion, side-hole cutting, flap formation or pigtail memory can materially affect placement and drainage performance, making manufacturing consistency critical. Regulatory requirements for biocompatibility, sterilization validation, shelf life, packaging integrity and post-market surveillance create meaningful barriers for smaller suppliers, particularly across the FDA, European MDR, NMPA and Japanese approval systems. Product differentiation is also difficult because established stent geometries are mature and clinicians often retain strong preferences for particular shapes, pushers and guidewire workflows. Price competition from regional manufacturers may compress margins before new materials or coatings achieve sufficient clinical evidence for premium positioning. At the same time, metal stents, endoscopic ultrasound-guided drainage and evolving stone-extraction technologies can reduce demand in selected indications. Suppliers therefore face the combined challenge of proving clinical value, maintaining a wide inventory of low-volume sizes and supporting geographically fragmented hospital procurement channels.
Industry Chain Analysis
The upstream chain comprises medical-grade polyethylene, PTFE, polyurethane and EVA polymers; radiopaque fillers or markers; colorants; guidewire-compatible tubing; stainless-steel or polymeric pusher components; and sterile barrier packaging. Midstream manufacturing involves precision extrusion, lumen control, thermal shaping, tapering, side-hole and flap formation, pigtail setting, radiopaque integration, assembly with pushers or introducers, cleanroom packaging and validated sterilization. Competitive value is created through consistent inner diameter, controlled stiffness, shape retention, visibility, drainage efficiency and compatibility with endoscopes and guidewires. Product owners may manufacture internally, use qualified OEM partners or combine proprietary delivery systems with outsourced polymer components. Downstream customers are hospitals, endoscopy centers, transplant and hepatobiliary units and, for selected products, interventional radiology departments. Sales occur through direct hospital accounts, group purchasing organizations, regional distributors and tender platforms. Because the stent itself uses relatively inexpensive polymer, a substantial share of value derives from design know-how, delivery-system integration, regulatory registration, quality assurance, inventory breadth, clinician training and dependable availability during urgent ERCP procedures.
Segment Insights
Straight Stent covers conventional straight, duodenal-bend, center-bend and Tannenbaum-style flapped products without curled retention ends; this category represents the broadest routine unit base because it supports multiple diameters, lengths and general drainage indications. Pigtail Stent includes single- and double-pigtail configurations and is differentiated by loop-based retention, making it relevant where migration prevention, stable cavity drainage or complex anatomy is important. Other comprises inside-stent designs, double-layer products, specialized preassembled geometries and percutaneous-to-internal conversion systems. Although smaller in volume, this category offers greater differentiation and potentially stronger pricing resilience.
Additional segmentation should be applied by material, diameter and delivery configuration. Material categories comprise polyethylene, PTFE, polyurethane, EVA and other polymer blends; diameter bands can be organized as up to 7 Fr, 8–8.5 Fr, 10 Fr, and above 10 Fr; delivery categories comprise stand-alone stents, stent-and-pusher sets and preloaded introducer systems. By application, benign biliary strictures and stone-related temporary drainage support recurring procedure volumes, malignant obstruction provides selective short-duration or bridge demand, and bile leak or biliary fistula represents a smaller but procedure-critical segment. This multidimensional structure is more decision-useful than classifying products solely by external shape.
Downstream Market Opportunities
Hospitals with therapeutic ERCP capability remain the primary end users, with tertiary referral centers contributing disproportionate demand for complex strictures, transplantation cases, hilar drainage and difficult stones. Community hospitals and ambulatory endoscopy centers offer opportunities for simplified preloaded products that reduce setup steps and training requirements. Benign stricture management is an attractive recurring-consumption application because treatment can require multiple simultaneous stents and scheduled exchanges. Stone-related drainage provides dependable procedural demand when infection, anatomy or stone size prevents immediate clearance, while postoperative bile leaks create time-sensitive requirements for readily available standard sizes. Interventional radiology represents a differentiated channel for plastic systems that convert external drainage to an internal stent. Suppliers can expand downstream penetration through procedure-specific kits, guidewire compatibility, consignment inventory, clinical education and digital inventory management rather than competing only on the price of an individual stent.
Regional Insights
North America remains the largest high-value regional market, supported by extensive therapeutic endoscopy infrastructure, established reimbursement pathways and strong adoption of integrated ERCP product platforms. Its competitive structure favors suppliers combining stents, guidewires, sphincterotomes, balloons and clinical support. Europe is another mature demand center, but procurement is more fragmented and MDR compliance increases registration and lifecycle-management costs, creating opportunities for established German and Belgian specialist manufacturers. Asia-Pacific provides the strongest incremental unit-growth potential. China combines expanding ERCP capacity, domestic manufacturing and tender-driven price competition; Japan maintains advanced clinical practice and demand for specialized inside, pigtail and multilayer designs; South Korea has strong therapeutic-endoscopy capability, while Southeast Asian demand depends more heavily on imported products and distributor networks. Latin America, the Middle East and Africa remain smaller but addressable markets, with growth concentrated in private hospitals and tertiary public centers. Across emerging regions, market access depends as much on training, registration and product availability as on nominal device price.
Competitive Landscape Analysis
Boston Scientific, Cook Medical and Olympus constitute the global core of the competitive landscape because they combine plastic stents with extensive ERCP instruments, delivery systems, physician relationships and multinational regulatory coverage. Boston Scientific differentiates through Advanix flow, repositionability and preloaded NaviFlex configurations; Cook Medical offers multiple established plastic-stent families and broad material, shape and delivery choices; Olympus competes through endoscopy-system integration and double-layer stent technology. Micro-Tech Endoscopy is a validated international challenger with plastic stents, introducers and short-wire-compatible sets cleared through the FDA’s 510(k) pathway. ENDO-FLEX, within the Medi-Globe Group, provides a wide PE/PTFE matrix covering straight, curved, angled and double-pigtail designs and should be consolidated with its group when evaluating competitive concentration. Hobbs Medical, optimed and G-Flex are credible specialist suppliers in the United States and Europe, while Japan Lifeline and Frankenman extend the verified regional manufacturer pool in Japan and China. Merit Medical Systems participates in a narrower interventional-radiology segment through its ReSolve ConvertX internalized plastic biliary stent and is not a direct like-for-like competitor across the full ERCP market. Competition centers on portfolio breadth, delivery reliability, polymer performance, regulatory access, hospital coverage and price rather than on a single proprietary stent mechanism.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Plastic Biliary Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Boston Scientific
Cook Medical
Olympus Corporation
ENDO-FLEX GmbH
Micro-Tech Endoscopy
Merit Medical Systems
Segment by Type
Straight Stent
Pigtail Stent
Other
Segment by Polymer Material
Polyethylene
Polyurethane
Polytetrafluoroethylene
EVA Copolymer
Other
Segment by Diameter
Diameter≤8Fr
Diameter 8-10Fr
Diameter>10Fr
Segment by Application
Benign Biliary Strictures,Bbs
Malignant Biliary Obstruction
Bile Duct Stones
Gallbladder Leakage And Fistula
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Plastic Biliary Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Plastic Biliary Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Plastic Biliary Stent Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Straight Stent
1.2.3 Pigtail Stent
1.2.4 Other
1.3 Market Segmentation by Polymer Material
1.3.1 Global Plastic Biliary Stent Market Size by Polymer Material, 2021 vs 2025 vs 2032
1.3.2 Polyethylene
1.3.3 Polyurethane
1.3.4 Polytetrafluoroethylene
1.3.5 EVA Copolymer
1.3.6 Other
1.4 Market Segmentation by Diameter
1.4.1 Global Plastic Biliary Stent Market Size by Diameter, 2021 vs 2025 vs 2032
1.4.2 Diameter≤8Fr
1.4.3 Diameter 8-10Fr
1.4.4 Diameter>10Fr
1.5 Market Segmentation by Application
1.5.1 Global Plastic Biliary Stent Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Benign Biliary Strictures,Bbs
1.5.3 Malignant Biliary Obstruction
1.5.4 Bile Duct Stones
1.5.5 Gallbladder Leakage And Fistula
1.5.6 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Plastic Biliary Stent Revenue Estimates and Forecasts (2021-2032)
2.2 Global Plastic Biliary Stent Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Plastic Biliary Stent Sales Estimates and Forecasts (2021-2032)
2.4 Global Plastic Biliary Stent Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Plastic Biliary Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Plastic Biliary Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Straight Stent: Market Share by Key Manufacturers
3.5.2 Pigtail Stent: Market Share by Key Manufacturers
3.5.3 Other: Market Share by Key Manufacturers
3.6 Global Plastic Biliary Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Plastic Biliary Stent Sales Performance by Type
4.1.1 Global Plastic Biliary Stent Sales Volume by Type (2021-2032)
4.1.2 Global Plastic Biliary Stent Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Plastic Biliary Stent Sales Performance by Polymer Material
4.2.1 Global Plastic Biliary Stent Sales Volume by Polymer Material (2021-2032)
4.2.2 Global Plastic Biliary Stent Revenue by Polymer Material (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Polymer Material (2021-2032)
4.3 Global Plastic Biliary Stent Sales Performance by Diameter
4.3.1 Global Plastic Biliary Stent Sales Volume by Diameter (2021-2032)
4.3.2 Global Plastic Biliary Stent Revenue by Diameter (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Diameter (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Plastic Biliary Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Plastic Biliary Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Plastic Biliary Stent Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Plastic Biliary Stent Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Plastic Biliary Stent Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Plastic Biliary Stent Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Plastic Biliary Stent Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Plastic Biliary Stent Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Plastic Biliary Stent Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Plastic Biliary Stent Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Plastic Biliary Stent Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Plastic Biliary Stent Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Plastic Biliary Stent Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Plastic Biliary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Boston Scientific Plastic Biliary Stent Sales by Product in 2025
11.1.6 Boston Scientific Plastic Biliary Stent Sales by Application in 2025
11.1.7 Boston Scientific Plastic Biliary Stent Sales by Geographic Area in 2025
11.1.8 Boston Scientific Plastic Biliary Stent SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Cook Medical
11.2.1 Cook Medical Corporation Information
11.2.2 Cook Medical Business Overview
11.2.3 Cook Medical Plastic Biliary Stent Product Models, Descriptions and Specifications
11.2.4 Cook Medical Plastic Biliary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Cook Medical Plastic Biliary Stent Sales by Product in 2025
11.2.6 Cook Medical Plastic Biliary Stent Sales by Application in 2025
11.2.7 Cook Medical Plastic Biliary Stent Sales by Geographic Area in 2025
11.2.8 Cook Medical Plastic Biliary Stent SWOT Analysis
11.2.9 Cook Medical Recent Developments
11.3 Olympus Corporation
11.3.1 Olympus Corporation Corporation Information
11.3.2 Olympus Corporation Business Overview
11.3.3 Olympus Corporation Plastic Biliary Stent Product Models, Descriptions and Specifications
11.3.4 Olympus Corporation Plastic Biliary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Olympus Corporation Plastic Biliary Stent Sales by Product in 2025
11.3.6 Olympus Corporation Plastic Biliary Stent Sales by Application in 2025
11.3.7 Olympus Corporation Plastic Biliary Stent Sales by Geographic Area in 2025
11.3.8 Olympus Corporation Plastic Biliary Stent SWOT Analysis
11.3.9 Olympus Corporation Recent Developments
11.4 ENDO-FLEX GmbH
11.4.1 ENDO-FLEX GmbH Corporation Information
11.4.2 ENDO-FLEX GmbH Business Overview
11.4.3 ENDO-FLEX GmbH Plastic Biliary Stent Product Models, Descriptions and Specifications
11.4.4 ENDO-FLEX GmbH Plastic Biliary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 ENDO-FLEX GmbH Plastic Biliary Stent Sales by Product in 2025
11.4.6 ENDO-FLEX GmbH Plastic Biliary Stent Sales by Application in 2025
11.4.7 ENDO-FLEX GmbH Plastic Biliary Stent Sales by Geographic Area in 2025
11.4.8 ENDO-FLEX GmbH Plastic Biliary Stent SWOT Analysis
11.4.9 ENDO-FLEX GmbH Recent Developments
11.5 Micro-Tech Endoscopy
11.5.1 Micro-Tech Endoscopy Corporation Information
11.5.2 Micro-Tech Endoscopy Business Overview
11.5.3 Micro-Tech Endoscopy Plastic Biliary Stent Product Models, Descriptions and Specifications
11.5.4 Micro-Tech Endoscopy Plastic Biliary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Micro-Tech Endoscopy Plastic Biliary Stent Sales by Product in 2025
11.5.6 Micro-Tech Endoscopy Plastic Biliary Stent Sales by Application in 2025
11.5.7 Micro-Tech Endoscopy Plastic Biliary Stent Sales by Geographic Area in 2025
11.5.8 Micro-Tech Endoscopy Plastic Biliary Stent SWOT Analysis
11.5.9 Micro-Tech Endoscopy Recent Developments
11.6 Merit Medical Systems
11.6.1 Merit Medical Systems Corporation Information
11.6.2 Merit Medical Systems Business Overview
11.6.3 Merit Medical Systems Plastic Biliary Stent Product Models, Descriptions and Specifications
11.6.4 Merit Medical Systems Plastic Biliary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Merit Medical Systems Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Plastic Biliary Stent Industry Chain
12.2 Plastic Biliary Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Plastic Biliary Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Plastic Biliary Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Plastic Biliary Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Plastic Biliary Stent Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Plastic Biliary Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Plastic Biliary Stent Market Size Growth Rate by Polymer Material, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Plastic Biliary Stent Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Plastic Biliary Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Plastic Biliary Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Plastic Biliary Stent Revenue by Region (US$ Million), 2021-2026
Table 7. Global Plastic Biliary Stent Revenue by Region (US$ Million), 2027-2032
Table 8. Global Plastic Biliary Stent Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Plastic Biliary Stent Sales by Region (K Units), 2021-2026
Table 10. Global Plastic Biliary Stent Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Plastic Biliary Stent Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Plastic Biliary Stent Sales Share by Manufacturers (2021-2026)
Table 14. Global Plastic Biliary Stent Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Plastic Biliary Stent Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Plastic Biliary Stent Revenue, 2025
Table 18. Global Plastic Biliary Stent Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Plastic Biliary Stent Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Plastic Biliary Stent Manufacturing Base and Headquarters
Table 21. Global Plastic Biliary Stent Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Plastic Biliary Stent Sales Volume by Type (K Units), 2021-2026
Table 25. Global Plastic Biliary Stent Sales Volume by Type (K Units), 2027-2032
Table 26. Global Plastic Biliary Stent Revenue by Type (US$ Million), 2021-2026
Table 27. Global Plastic Biliary Stent Revenue by Type (US$ Million), 2027-2032
Table 28. Global Plastic Biliary Stent Sales Volume by Polymer Material (K Units), 2021-2026
Table 29. Global Plastic Biliary Stent Sales Volume by Polymer Material (K Units), 2027-2032
Table 30. Global Plastic Biliary Stent Revenue by Polymer Material (US$ Million), 2021-2026
Table 31. Global Plastic Biliary Stent Revenue by Polymer Material (US$ Million), 2027-2032
Table 32. Global Plastic Biliary Stent Sales Volume by Diameter (K Units), 2021-2026
Table 33. Global Plastic Biliary Stent Sales Volume by Diameter (K Units), 2027-2032
Table 34. Global Plastic Biliary Stent Revenue by Diameter (US$ Million), 2021-2026
Table 35. Global Plastic Biliary Stent Revenue by Diameter (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Plastic Biliary Stent Sales by Application (K Units), 2021-2026
Table 38. Global Plastic Biliary Stent Sales by Application (K Units), 2027-2032
Table 39. Plastic Biliary Stent High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Plastic Biliary Stent Revenue by Application (US$ Million), 2021-2026
Table 41. Global Plastic Biliary Stent Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Plastic Biliary Stent Growth Accelerators and Market Barriers
Table 45. North America Plastic Biliary Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Plastic Biliary Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Plastic Biliary Stent Growth Accelerators and Market Barriers
Table 48. Europe Plastic Biliary Stent Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Plastic Biliary Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Plastic Biliary Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Plastic Biliary Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Plastic Biliary Stent Growth Accelerators and Market Barriers
Table 53. Southeast Asia Plastic Biliary Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Plastic Biliary Stent Investment Opportunities and Key Challenges
Table 55. Central and South America Plastic Biliary Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Plastic Biliary Stent Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Plastic Biliary Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Boston Scientific Corporation Information
Table 59. Boston Scientific Description and Major Businesses
Table 60. Boston Scientific Product Models, Descriptions and Specifications
Table 61. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Boston Scientific Sales Value Proportion by Product in 2025
Table 63. Boston Scientific Sales Value Proportion by Application in 2025
Table 64. Boston Scientific Sales Value Proportion by Geographic Area in 2025
Table 65. Boston Scientific Plastic Biliary Stent SWOT Analysis
Table 66. Boston Scientific Recent Developments
Table 67. Cook Medical Corporation Information
Table 68. Cook Medical Description and Major Businesses
Table 69. Cook Medical Product Models, Descriptions and Specifications
Table 70. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Cook Medical Sales Value Proportion by Product in 2025
Table 72. Cook Medical Sales Value Proportion by Application in 2025
Table 73. Cook Medical Sales Value Proportion by Geographic Area in 2025
Table 74. Cook Medical Plastic Biliary Stent SWOT Analysis
Table 75. Cook Medical Recent Developments
Table 76. Olympus Corporation Corporation Information
Table 77. Olympus Corporation Description and Major Businesses
Table 78. Olympus Corporation Product Models, Descriptions and Specifications
Table 79. Olympus Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Olympus Corporation Sales Value Proportion by Product in 2025
Table 81. Olympus Corporation Sales Value Proportion by Application in 2025
Table 82. Olympus Corporation Sales Value Proportion by Geographic Area in 2025
Table 83. Olympus Corporation Plastic Biliary Stent SWOT Analysis
Table 84. Olympus Corporation Recent Developments
Table 85. ENDO-FLEX GmbH Corporation Information
Table 86. ENDO-FLEX GmbH Description and Major Businesses
Table 87. ENDO-FLEX GmbH Product Models, Descriptions and Specifications
Table 88. ENDO-FLEX GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. ENDO-FLEX GmbH Sales Value Proportion by Product in 2025
Table 90. ENDO-FLEX GmbH Sales Value Proportion by Application in 2025
Table 91. ENDO-FLEX GmbH Sales Value Proportion by Geographic Area in 2025
Table 92. ENDO-FLEX GmbH Plastic Biliary Stent SWOT Analysis
Table 93. ENDO-FLEX GmbH Recent Developments
Table 94. Micro-Tech Endoscopy Corporation Information
Table 95. Micro-Tech Endoscopy Description and Major Businesses
Table 96. Micro-Tech Endoscopy Product Models, Descriptions and Specifications
Table 97. Micro-Tech Endoscopy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Micro-Tech Endoscopy Sales Value Proportion by Product in 2025
Table 99. Micro-Tech Endoscopy Sales Value Proportion by Application in 2025
Table 100. Micro-Tech Endoscopy Sales Value Proportion by Geographic Area in 2025
Table 101. Micro-Tech Endoscopy Plastic Biliary Stent SWOT Analysis
Table 102. Micro-Tech Endoscopy Recent Developments
Table 103. Merit Medical Systems Corporation Information
Table 104. Merit Medical Systems Description and Major Businesses
Table 105. Merit Medical Systems Product Models, Descriptions and Specifications
Table 106. Merit Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Merit Medical Systems Recent Developments
Table 108. Key Raw Materials Distribution
Table 109. Raw Materials Key Suppliers
Table 110. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 111. Milestones in Production Technology Evolution
Table 112. Distributors List
Table 113. Market Trends and Market Evolution
Table 114. Market Drivers and Opportunities
Table 115. Market Challenges, Risks, and Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List of Figures
Figure 1. Plastic Biliary Stent Product Picture
Figure 2. Global Plastic Biliary Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Straight Stent Product Picture
Figure 4. Pigtail Stent Product Picture
Figure 5. Other Product Picture
Figure 6. Global Plastic Biliary Stent Market Size Growth Rate by Polymer Material, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Polyethylene Product Picture
Figure 8. Polyurethane Product Picture
Figure 9. Polytetrafluoroethylene Product Picture
Figure 10. EVA Copolymer Product Picture
Figure 11. Other Product Picture
Figure 12. Global Plastic Biliary Stent Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Diameter≤8Fr Product Picture
Figure 14. Diameter 8-10Fr Product Picture
Figure 15. Diameter>10Fr Product Picture
Figure 16. Global Plastic Biliary Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Benign Biliary Strictures,Bbs
Figure 18. Malignant Biliary Obstruction
Figure 19. Bile Duct Stones
Figure 20. Gallbladder Leakage And Fistula
Figure 21. Other
Figure 22. Plastic Biliary Stent Report Years Considered
Figure 23. Global Plastic Biliary Stent Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 25. Global Plastic Biliary Stent Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 26. Global Plastic Biliary Stent Revenue-Based Market Share by Region (2021-2032)
Figure 27. Global Plastic Biliary Stent Sales (K Units), 2021-2032
Figure 28. Global Plastic Biliary Stent Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 29. Global Plastic Biliary Stent Sales Market Share by Region (2021-2032)
Figure 30. Top 5 and Top 10 Manufacturers Plastic Biliary Stent Sales Volume Market Share in 2025
Figure 31. Global Plastic Biliary Stent Revenue-Based Market Share Ranking (2025)
Figure 32. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 33. Straight Stent Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Pigtail Stent Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 36. Global Plastic Biliary Stent Sales Volume-Based Market Share by Type (2021-2032)
Figure 37. Global Plastic Biliary Stent Revenue-Based Market Share by Type (2021-2032)
Figure 38. Global Plastic Biliary Stent ASP by Type (US$/Unit), 2021-2032
Figure 39. Global Plastic Biliary Stent Sales Volume-Based Market Share by Polymer Material (2021-2032)
Figure 40. Global Plastic Biliary Stent Revenue-Based Market Share by Polymer Material (2021-2032)
Figure 41. Global Plastic Biliary Stent ASP by Polymer Material (US$/Unit), 2021-2032
Figure 42. Global Plastic Biliary Stent Sales Volume-Based Market Share by Diameter (2021-2032)
Figure 43. Global Plastic Biliary Stent Revenue-Based Market Share by Diameter (2021-2032)
Figure 44. Global Plastic Biliary Stent ASP by Diameter (US$/Unit), 2021-2032
Figure 45. Global Plastic Biliary Stent Sales Market Share by Application (2021-2032)
Figure 46. Global Plastic Biliary Stent Revenue-Based Market Share by Application (2021-2032)
Figure 47. Global Plastic Biliary Stent ASP by Application (US$/Unit), 2021-2032
Figure 48. North America Plastic Biliary Stent Sales YoY (K Units), 2021-2032
Figure 49. North America Plastic Biliary Stent Revenue YoY (US$ Million), 2021-2032
Figure 50. North America Top 5 Manufacturers Plastic Biliary Stent Sales Revenue (US$ Million) in 2025
Figure 51. North America Plastic Biliary Stent Sales Volume (K Units) by Application (2021-2032)
Figure 52. North America Plastic Biliary Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 53. US Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 54. Canada Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 55. Mexico Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 56. Europe Plastic Biliary Stent Sales YoY (K Units), 2021-2032
Figure 57. Europe Plastic Biliary Stent Revenue YoY (US$ Million), 2021-2032
Figure 58. Europe Top 5 Manufacturers Plastic Biliary Stent Sales Revenue (US$ Million) in 2025
Figure 59. Europe Plastic Biliary Stent Sales Volume (K Units) by Application (2021-2032)
Figure 60. Europe Plastic Biliary Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 61. Germany Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 62. France Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 63. U.K. Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 64. Italy Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 65. Russia Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 66. Asia-Pacific Plastic Biliary Stent Sales YoY (K Units), 2021-2032
Figure 67. Asia-Pacific Plastic Biliary Stent Revenue YoY (US$ Million), 2021-2032
Figure 68. Asia-Pacific Top 8 Manufacturers Plastic Biliary Stent Sales Revenue (US$ Million) in 2025
Figure 69. Asia-Pacific Plastic Biliary Stent Sales Volume (K Units) by Application (2021-2032)
Figure 70. Asia-Pacific Plastic Biliary Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 71. Indonesia Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 72. Japan Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 73. South Korea Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 74. China Taiwan Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 75. India Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 76. Central and South America Plastic Biliary Stent Sales YoY (K Units), 2021-2032
Figure 77. Central and South America Plastic Biliary Stent Revenue YoY (US$ Million), 2021-2032
Figure 78. Central and South America Top 5 Manufacturers Plastic Biliary Stent Sales Revenue (US$ Million) in 2025
Figure 79. Central and South America Plastic Biliary Stent Sales Volume (K Units) by Application (2021-2032)
Figure 80. Central and South America Plastic Biliary Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 81. Brazil Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 82. Argentina Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 83. Middle East, and Africa Plastic Biliary Stent Sales YoY (K Units), 2021-2032
Figure 84. Middle East and Africa Plastic Biliary Stent Revenue YoY (US$ Million), 2021-2032
Figure 85. Middle East and Africa Top 5 Manufacturers Plastic Biliary Stent Sales Revenue (US$ Million) in 2025
Figure 86. Middle East and Africa Plastic Biliary Stent Sales Volume (K Units) by Application (2021-2032)
Figure 87. Middle East and Africa Plastic Biliary Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 88. GCC Countries Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 89. Turkey Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 90. Egypt Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 91. South Africa Plastic Biliary Stent Revenue (US$ Million), 2021-2032
Figure 92. Plastic Biliary Stent Industry Chain Mapping
Figure 93. Regional Plastic Biliary Stent Manufacturing Base Distribution (%)
Figure 94. Global Plastic Biliary Stent Production Market Share by Region (2021-2032)
Figure 95. Plastic Biliary Stent Production Process
Figure 96. Regional Plastic Biliary Stent Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed